39 results
Page 2 of 2
8-K
EX-1.1
21yso
21 Sep 18
Viking Therapeutics Announces Pricing of $175.8 Million Public Offering of Common Stock
6:05am
424B5
ajxguhm y5ha
19 Sep 18
Prospectus supplement for primary offering
4:27pm
424B5
kpz4r827cjoax2ti
7 Jun 18
Prospectus supplement for primary offering
5:13pm
8-K
EX-1.1
dnl9jt115 fl
7 Jun 18
Viking Therapeutics Announces Pricing of $67.5 Million Public Offering of Common Stock
1:41pm
424B5
3voib7q95
6 Jun 18
Prospectus supplement for primary offering
4:11pm
424B4
zr5m4mfvl58c
8 Apr 16
Prospectus supplement with pricing info
12:00am
10-K
ld2mxt4o0ows9co61ph
8 Mar 16
Annual report
12:00am
CORRESP
p6jxrsv0ms
19 Sep 14
Correspondence with SEC
12:00am
CORRESP
m5ztq7z75
16 Sep 14
Correspondence with SEC
12:00am